Interfering with glutamatergic neurotransmission by means of NMDA antagonist administration discloses the locomotor stimulatory potential of other transmitter systems
- 1 May 1990
- journal article
- research article
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 36 (1), 45-50
- https://doi.org/10.1016/0091-3057(90)90123-y
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted miceJournal of Neural Transmission, 1989
- Comparison of the behavioral and biochemical effects of the NMDA receptor antagonists, MK-801 and phencyclidineEuropean Journal of Pharmacology, 1989
- Dramatic synergism between MK-801 and clonidine with respect to locomotor stimulatory effect in monoamine-depleted miceJournal of Neural Transmission, 1989
- A “Glutamatergic Hypothesis” of SchizophreniaClinical Neuropharmacology, 1989
- Sub types of α2-adrenoceptors: Pharmacological and molecular biological evidence convergTrends in Pharmacological Sciences, 1988
- The current status of the dopamine hypothesis of schizophreniaNeuropsychopharmacology, 1988
- The pharmacological selectivity of three NMDA antagonistsEuropean Journal of Pharmacology, 1988
- Physostigmine and haloperidol treatment of acute phencyclidine intoxicationAmerican Journal of Psychiatry, 1982
- Central sympathomimetic activity of (+)‐5‐methyl‐10,11‐dihydro‐5H‐dibenzo [a, d]cyclohepten‐5,10‐imine (MK‐801), a substance with potent anticonvulsant, central sympathomimetic, and apparent anxiolytic propertiesDrug Development Research, 1982
- Opiate-receptor mediated changes in monoamine synthesis in rat brainJournal of Pharmacy and Pharmacology, 1978